Coherus BioSciences Reports Third Quarter 2015 Financial and Operating Results and Corporate Events

Go back to Coherus BioSciences Reports Third Quarter 2015 Financial and Operating Results and Corporate Events

Coherus BioSciences (CHRS) Reports Q3 Loss Per Share of $1.86

November 9, 2015 4:43 PM EST

Coherus BioSciences (NASDAQ: CHRS) reported Q3 EPS of ($1.86), versus ($1.79) reported last year. Revenue for the quarter came in at $7.2 million, versus $16.1 million reported last year.

For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.

... More